Lu Yu
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent.
Journal: International journal of molecular sciences
Published: February 26, 2023
Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway.
Journal: Biochemical pharmacology
Published: January 07, 2023
PRR16/Largen Induces Epithelial-Mesenchymal Transition through the Interaction with ABI2 Leading to the Activation of ABL1 Kinase.
Journal: Biomolecules & therapeutics
Published: May 15, 2022
Loss of EMP2 Inhibits Melanogenesis of MNT1 Melanoma Cells via Regulation of TRP-2.
Journal: Biomolecules & therapeutics
Published: January 03, 2022
Resolvin D1 Suppresses H2O2-Induced Senescence in Fibroblasts by Inducing Autophagy through the miR-1299/ARG2/ARL1 Axis.
Journal: Antioxidants (Basel, Switzerland)
Published: October 30, 2021
LW1497, an Inhibitor of Malate Dehydrogenase, Suppresses TGF-β1-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells by Downregulating Slug.
Journal: Antioxidants (Basel, Switzerland)
Published: August 28, 2021
Ethacrynic acid, a loop diuretic, suppresses epithelial-mesenchymal transition of A549 lung cancer cells via blocking of NDP-induced WNT signaling.
Journal: Biochemical pharmacology
Published: August 10, 2020
SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin.
Journal: Journal of cellular physiology
Published: March 05, 2019
YdjC chitooligosaccharide deacetylase homolog induces keratin reorganization in lung cancer cells: involvement of interaction between YDJC and CDC16.
Journal: Oncotarget
Published: November 22, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026